This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $417.65, moving +0.65% from the previous trading session.
Cigna (CI) Q1 Earnings Beat Mark, Rise Y/Y on Revenue Gains
by Zacks Equity Research
Cigna's (CI) Q1 results reflect higher pharmacy revenues, and fees and other income.
The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, PayPal, NextEra Energy, Thermo Fisher Scientific and Anheuser-Busch InBev
Top Stock Reports for UnitedHealth, PayPal & NextEra
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), PayPal (PYPL), and NextEra (NEE).
Magellan Health's (MGLN) Q1 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
Magellan Health's (MGLN) Q1 results reflect better performances by its Heathcare and Pharmacy Management segments.
Molina Healthcare's (MOH) Q1 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter earnings gain from higher revenues and increased membership in Medicaid and Marketplace.
Humana's (HUM) Q1 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) Q1 earnings gain from better revenues and a solid contribution by its Retail segment.
Healthcare ETFs on Radar As Q1 Earnings Unfold
by Sweta Killa
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.
If You Invested $1000 in UnitedHealth Group 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Centene (CNC) Q1 Earnings Miss Estimates, Hikes '21 View
by Zacks Equity Research
Centene's (CNC) first-quarter results reflect higher revenues and growing Medicare as well as Medicaid membership, partly offset by escalating costs.
Universal Health (UHS) Q1 Earnings Top, Revenues Improve Y/Y
by Zacks Equity Research
Universal Health's (UHS) first-quarter results highlight uptick in revenues across both the company's segments, partly offset by escalating costs.
If You Invested $1000 in UnitedHealth Group a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Humana (HUM) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Humana's (HUM) first-quarter results are likely to reflect better revenues and strong Medicaid and Medicare businesses, partly offset by Specialty business and high costs.
What's in Offing for Teladoc Health's (TDOC) Earnings in Q1?
by Zacks Equity Research
Teladoc's (TDOC) Q1 results are likely to reflect higher revenues, partly offset by inflated expenses.
What's in Store for Universal Health's (UHS) Q1 Earnings?
by Zacks Equity Research
Universal Health's (UHS) first-quarter earnings are expected to have gained from better revenues and performances by its Acute Care and Behavioral Health segments.
HCA Healthcare's (HCA) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) first-quarter results highlight higher revenues, partly offset by increased costs.
Zacks Market Edge Highlights: Fastenal, UnitedHealth Group, Logitech, Panasonic and QQQM
by Zacks Equity Research
Zacks Market Edge Highlights: Fastenal, UnitedHealth Group, Logitech, Panasonic and QQQM
Where Should You Be Investing as the Economy Recovers?
by Tracey Ryniec
Forget about a US recession in 2021. The concern is about the possibility of overheating and inflation.
Anthem's (ANTM) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q1 earnings gain from better revenues and strong Medicaid and Medicare businesses.
UnitedHealth (UNH) to Help Eligible Medicaid Members in Ohio
by Zacks Equity Research
UnitedHealth (UNH) intends to improve health outcomes of eligible Medicaid members in Ohio where it already boasts a strong presence.
Are Healthcare ETFs Poised for a Comeback?
by Sanghamitra Saha
Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.
The Zacks Analyst Blog Highlights: UnitedHealth, Pfizer, Accenture, Wells Fargo and Uber
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth, Pfizer, Accenture, Wells Fargo and Uber
Top Research Reports for UnitedHealth, Pfizer & Accenture
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group (UNH), Pfizer (PFE), and Accenture (ACN).
Healthcare ETFs to Gain on UnitedHealth's Strong Q1 Earnings
by Sweta Killa
UnitedHealth Group (UNH) reported better-than-expected first-quarter 2021 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full-year earnings outlook.
Stock Market News for Apr 16, 2021
by Zacks Equity Research
Benchmark hit new records on Thursday as rebound in consumer spending and a buoyant jobs market attested economic recovery along with better-than-expected Q1 earnings reports.